Clinical Significance of Candida in Urine Culture
In most cases, Candida growth in urine culture represents colonization rather than true infection and does not require treatment unless the patient has specific symptoms or high-risk features.
Key Principle: Colonization vs. Infection
The fundamental challenge with candiduria is distinguishing benign colonization from true infection. In asymptomatic patients, candiduria almost always represents colonization 1. Multiple studies confirm that candiduria does not commonly lead to candidemia, and while it may be a marker for greater mortality, death is not related to Candida infection itself—treatment does not change mortality rates 1.
When Candiduria is NOT Clinically Significant (Do Not Treat)
According to the 2016 IDSA guidelines, the following patients should NOT be screened or treated for asymptomatic candiduria 1:
- Asymptomatic patients without risk factors
- Patients with well-regulated diabetes mellitus
- Postmenopausal women
- Elderly institutionalized patients
- Patients with dysfunctional/reconstructed lower urinary tract
- Renal transplant recipients
- Patients before arthroplasty surgery
- Patients with recurrent UTIs
Critical caveat: Diagnostic tests are often unhelpful—pyuria cannot differentiate infection from colonization, and colony counts (especially with catheters present) cannot define infection 1.
When Candiduria IS Clinically Significant (Requires Treatment)
High-Risk Populations Requiring Aggressive Approach:
Neonates with very low birth weight - at risk for invasive candidiasis involving urinary tract 1
Patients undergoing urological procedures - high rate of candidemia documented with urinary tract instrumentation; treat periprocedurally 1
Pregnant women - screen and treat with standard short-course therapy or single-dose fosfomycin 2
Before urological procedures breaching the mucosa - screen and treat 2
Symptomatic Patients:
Treat when patients have clear symptoms of cystitis or pyelonephritis that cannot be attributed to another pathogen 1. Candida UTI develops via two routes:
- Ascending infection (most common): symptoms of cystitis/pyelonephritis
- Hematogenous spread: usually no urinary symptoms; treat as candidemia 1
Treatment Algorithm When Indicated
For Symptomatic Cystitis:
- Fluconazole-susceptible species: Oral fluconazole 200 mg (3 mg/kg) daily × 2 weeks 1
- Fluconazole-resistant C. glabrata: AmB deoxycholate 0.3-0.6 mg/kg daily × 1-7 days OR oral flucytosine 25 mg/kg 4× daily × 7-10 days 1
- C. krusei: AmB deoxycholate 0.3-0.6 mg/kg daily × 1-7 days 1
- Remove indwelling catheter if feasible (strong recommendation) 1
For Pyelonephritis:
- Fluconazole-susceptible: Oral fluconazole 200-400 mg (3-6 mg/kg) daily × 2 weeks 1
- Eliminate urinary tract obstruction (strong recommendation) 1
- Consider removal/replacement of nephrostomy tubes or stents 1
Common Pitfalls to Avoid
Overtreating asymptomatic candiduria: This is the most common error. Real-world data shows 31.3% of patients receiving antifungal therapy were treated unnecessarily 3. Templated microbiology comments reduced inappropriate prescribing from 48.1% to 34.0% 4.
Relying on colony counts or pyuria: These cannot differentiate colonization from infection, especially with catheters 1.
Using echinocandins for UTI: These achieve minimal urine concentrations and are generally ineffective 1.
Using lipid formulations of amphotericin B: These do not achieve adequate urine concentrations 1.
Risk Factors for Candiduria
Patients at highest risk include: elderly, female gender (strongest predictor with OR 1.81) 5, diabetic, indwelling urinary devices, antibiotic use, and prior surgical procedures 1, 6.
Imaging Considerations
When true infection is suspected, ultrasound is the preferred initial study to identify structural abnormalities, hydronephrosis, or fungus balls. CT is superior for detecting pyelonephritis or perinephric abscess 1. Fungus balls require surgical intervention as antifungals alone will not succeed 1.